Balyasny Asset Management’s Chemours CC Stock Holding History

Balyasny Asset Management’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-300,000	Closed	-$9.46M	–	2654
2023 Q4	$9.46M	Buy	+300,000	New	+$8.14M	0.02%	889

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

WHCM

Wolf Hill Capital Management Greenwich, Connecticut $1.03B AUM 80.44% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Balyasny Asset Management's CC Position: Q1 2026 in Review

Balyasny Asset Management sold out of Chemours (CC) in Q1 2026, closing a stake of 710,854 shares — an estimated $8.38M sold.

Balyasny Asset Management first reported a position in CC in Q1 2017 and held it in 29 quarters. The position peaked at $39.5M in Q4 2017. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

Balyasny Asset Management reported no remaining Chemours position as of Q1 2026 after selling out during the quarter.
Balyasny Asset Management sold 710,854 Chemours shares in Q1 2026, an estimated $8.38M.
Balyasny Asset Management first reported a position in Chemours in Q1 2017 and held it in 29 quarters.
Balyasny Asset Management's Chemours position peaked at $39.5M in Q4 2017.
448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.